InsiderTrades.com logo
Biden’s $374B Giveaway Into This Sector
From DTI   |   Ad
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Click here for the full story
Laura G. Eichorn net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Laura Eichorn Biography and Net Worth

Insider of Imago BioSciences
Laura Eichorn is a founding employee of Imago BioSciences, Inc. She brings to the team over 25 years of operational experience. As Imago’s Chief Operating Officer and Interim Chief Financial Officer, Ms. Eichorn manages finance, legal, human resources, communications and marketing-related activities.

Prior to joining Imago BioSciences, Ms. Eichorn was Vice President of Operations and Finance at FerroKin BioSciences, Inc., beginning as a founding employee in 2007 through the FerroKin acquisition in April 2012 by Shire Pharmaceuticals.

Ms. Eichorn began her career at New Enterprise Associates in Baltimore, MD in 1995. She went on to establish a US office for UK-based Abingworth Venture Management in 1997. She then went to work at DNA Sciences followed by DataHooks, Inc., both in the San Francisco Bay area. She has a Bachelor of Arts degree from Frostburg State University in international studies.

What is Laura G. Eichorn's net worth?

The estimated net worth of Laura G. Eichorn is at least $7.48 million as of December 27th, 2022. Ms. Eichorn owns 207,737 shares of Imago BioSciences stock worth more than $7,480,609 as of April 19th. This net worth estimate does not reflect any other investments that Ms. Eichorn may own. Additionally, Ms. Eichorn receives a salary of $456,060.00 as Insider at Imago BioSciences. Learn More about Laura G. Eichorn's net worth.

How old is Laura G. Eichorn?

Ms. Eichorn is currently 51 years old. There are 5 older executives and no younger executives at Imago BioSciences. The oldest executive at Imago BioSciences is Dr. Hugh Young Rienhoff Jr., M.D., CEO & Director, who is 70 years old. Learn More on Laura G. Eichorn's age.

What is Laura G. Eichorn's salary?

As the Insider of Imago BioSciences, Inc., Ms. Eichorn earns $456,060.00 per year. The highest earning executive at Imago BioSciences is Dr. Hugh Young Rienhoff Jr., M.D., CEO & Director, who commands a salary of $701,780.00 per year. Learn More on Laura G. Eichorn's salary.

How do I contact Laura G. Eichorn?

The corporate mailing address for Ms. Eichorn and other Imago BioSciences executives is 329 OYSTER POINT BLVD. 3RD FLOOR, SOUTH SAN FRANCISCO CA, 904080. Imago BioSciences can also be reached via phone at 415-529-5055 and via email at [email protected]. Learn More on Laura G. Eichorn's contact information.

Has Laura G. Eichorn been buying or selling shares of Imago BioSciences?

Laura G. Eichorn has not been actively trading shares of Imago BioSciences during the last quarter. Most recently, Laura G. Eichorn sold 3,100 shares of the business's stock in a transaction on Tuesday, December 27th. The shares were sold at an average price of $35.93, for a transaction totalling $111,383.00. Following the completion of the sale, the chief financial officer now directly owns 207,737 shares of the company's stock, valued at $7,463,990.41. Learn More on Laura G. Eichorn's trading history.

Who are Imago BioSciences' active insiders?

Imago BioSciences' insider roster includes Laura Eichorn (Insider), and Jennifer Peppe (Insider). Learn More on Imago BioSciences' active insiders.

Laura G. Eichorn Insider Trading History at Imago BioSciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/27/2022Sell3,100$35.93$111,383.00207,737View SEC Filing Icon  
11/2/2022Sell553$18.00$9,954.00207,737View SEC Filing Icon  
8/22/2022Sell447$18.00$8,046.00207,737View SEC Filing Icon  
8/17/2022Sell373$19.50$7,273.50207,737View SEC Filing Icon  
7/20/2022Sell1,000$18.00$18,000.00207,737View SEC Filing Icon  
2/22/2022Sell8,000$21.60$172,800.00View SEC Filing Icon  
See Full Table

Laura G. Eichorn Buying and Selling Activity at Imago BioSciences

This chart shows Laura G Eichorn's buying and selling at Imago BioSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Imago BioSciences Company Overview

Imago BioSciences logo
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Read More

Today's Range

Now: $36.01
Low: $36.01
High: $36.01

50 Day Range

MA: $35.96
Low: $35.78
High: $36.01

2 Week Range

Now: $36.01
Low: $11.56
High: $36.09

Volume

N/A

Average Volume

171,367 shs

Market Capitalization

$1.22 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.82
Biden’s $374B Giveaway Into This Sector
From DTI   |   Ad
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Click here for the full story